Thermo Fisher Scientific Inc. (TMO)

276.15
NYSE : Health Technology
Prev Close 273.31
Day Low/High 274.25 / 277.35
52 Wk Low/High 208.34 / 305.45
Avg Volume 1.43M
Exchange NYSE
Shares Outstanding 400.48M
Market Cap 109.45B
EPS 7.30
P/E Ratio 31.20
Div & Yield 0.76 (0.27%)
Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Spotify, Alkermes, Sorrento Therapeutics: 'Mad Money' Lightning Round

Jim Cramer highlights Spotify, Alkermes, Sorrento Therapeutics, Thermo Fisher Scientific, Kohlberg Kravis Roberts, and more.

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Who, out there in the health care sector, is safe?

Jim's Daily Rundown

Jim discusses GE, Comcast, Illinois Tool Works, and Abbott Labs, all of which reported earnings Wednesday morning.

Jim's Daily Rundown

In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

The New #181 Most Shorted S&P 500 Component: Thermo Fisher Scientific

The New #181 Most Shorted S&P 500 Component: Thermo Fisher Scientific

The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Jim's Daily Rundown

In today's video, Jim discusses our newest initiation in Constellation Brands, Danaher at the JP Morgan Healthcare conference, and energy stocks.

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR

You can make a case to buy any of the stocks of the companies at ICR.

Thermo Fisher Scientific Moves Up In Analyst Rankings, Passing Salesforce.com

Thermo Fisher Scientific Moves Up In Analyst Rankings, Passing Salesforce.com

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Thermo Fisher Scientific Inc has taken over the #14 spot from Salesforce. om Inc , according to ETF Channel.

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Amazon Could Gain 20% by Entering Health Care

Amazon Could Gain 20% by Entering Health Care

Moving into higher-margin products could boost Amazon's gross margins by 1,000 basis points, one analyst contends.

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon

It looks like China is building again.

Cramer: Here Are the Ideal Stocks Now

Cramer: Here Are the Ideal Stocks Now

All the great stocks have artificial intelligence and e-commerce in common.

Jim Cramer: Agilent Technology Has Been One of My Favorites

Jim Cramer: Agilent Technology Has Been One of My Favorites

What's next for shares of Agilent Technology.

Secondaries Get Primary Attention; Discerning Market -- Cramer's Top Thoughts

Secondaries Get Primary Attention; Discerning Market -- Cramer's Top Thoughts

Cramer examines how the secondaries are getting some primary attention and also observes that the market is becoming more discerning.

Cramer: Secondary Offerings Get Primary Attention

Cramer: Secondary Offerings Get Primary Attention

Thermo Fisher and McCormick deals show the true colors of stocks.

The Stock Market Is on Fire, Especially in These Sectors: Market Recon

The Stock Market Is on Fire, Especially in These Sectors: Market Recon

There is only an official statement. No press conference, no new projections.

Doing Some Shuffling in the Bullpen

We're adding Nvidia, removing TMO and Six Flags, plus 2 updates.

Thermo Fisher Scientific Moves Up In Analyst Rankings, Passing American Tower

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Thermo Fisher Scientific Inc has taken over the #6 spot from American Tower Corp , according to ETF Channel. Below is a chart of Thermo Fisher Scientific Inc versus American Tower Corp plotting their respective rank within the S&P 500 over time (TMO plotted in blue; AMT plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

After acquiring Amsterdam-based Patheon, TMO will continue its focus on collecting future companies into its back pocket.

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Ahead of Fed's June meeting, investors will need to start paying close attention to Fed officials and economic data.

Thermo Fisher Initiated With 'Overweight' Rating at Cantor Fitzgerald

Thermo Fisher Initiated With 'Overweight' Rating at Cantor Fitzgerald

Thermo Fisher's strong reputation with consumers in a 'highly-fragmented' industry will create organic growth opportunities at the 'likely' expense of weaker competition, Cantor said.

Analysts' Actions -- AK Steel, IBM, Nvidia, Walmart, Thermo Fisher and More

Analysts' Actions -- AK Steel, IBM, Nvidia, Walmart, Thermo Fisher and More

Here are Friday's top research calls, including an upgrade for Walmart and new coverage of AK Steel, IBM, Nvidia and Thermo Fisher.

Patheon Stock Spikes After Being Purchased by Thermo Fisher for $7.2 Billion

Patheon Stock Spikes After Being Purchased by Thermo Fisher for $7.2 Billion

The deal includes $2 billion in debt.

Wall Street Holds Solid Gains as Crude Oil, Energy Stocks Rally

Wall Street Holds Solid Gains as Crude Oil, Energy Stocks Rally

Stocks hold onto solid gains on Monday as crude oil and energy names rally on high hopes for an extension to a production cap agreement.

Stocks Get Lift From Rally in Crude Oil Prices, Energy Shares Gain

Stocks Get Lift From Rally in Crude Oil Prices, Energy Shares Gain

Stocks are higher on Monday after energy ministers from Russia and Saudi Arabia call for an extension to an oil production cap agreement.

Stock Futures Higher as Russia, Saudi Arabia Call for OPEC Deal Extension, Crude Jumps

Stock Futures Higher as Russia, Saudi Arabia Call for OPEC Deal Extension, Crude Jumps

Stock futures are higher on Monday after energy ministers from Russia and Saudi Arabia call for an extension to an oil production cap agreement.

TheStreet Quant Rating: A (Buy)